The two GLP-1 treatments available are sold under the brand names Byetta and Victoza. The drugs, however, are not very p…
Victoza
New Tresiba/Victoza Combination Therapy, IDegLira, Shows Improved Glucose Control and Weight Loss
IDegLira is a combination of Tresiba (insulin degludec), a once-daily basal insulin analogue with an ultra-long duration…
FDA To Re-Evaluate Type 2 Diabetes Drugs Following New Research
The FDA is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of panc…
New Observational Data Shows Patients Prefer Victoza
New data from observational studies in the UK shows that patients with type 2 diabetes experience greater reduction of H…
The Significance of the Victoza Product Label Update
Novo Nordisk’s widely popular GLP-1 analog Victoza made headlines at the beginning of the year when celebrity chef…
An Interview with Paula Deen: Adjusting to Life with Type 2 Diabetes
"Paula Deen is not the diabetes poster child," said Ambre Morely, associate director of product communications at Novo N…
Victoza on the Rise: Paula Deen Promotes Type 2 Diabetes Drug
Paula Deen has been privately suffering from type 2 diabetes for three years. Now she’s gone public with both her diabe…
Paula Deen Announces Type 2 Diabetes Diagnosis and Partners Up with Novo Nordisk
After days of rumors regarding Paula Deen's diabetes diagnosis, the woman dubbed the Queen of Southern Cuisine has annou…
Victoza, Novo Nordisk’s Type 2 Diabetes Drug, Available in China
Victoza, Novo Nordisks best selling type 2 diabetes drug is now commercially available in China. Victoza, (liraglutide i…
Eu Adopts Positive Opinion on Levemir as an Add-On Therapy to Victoza in Type 2 Diabetes Patients
Following a review of new data from a 52-week clinical trial, the European Committee for Medicinal Products for Human U…
